GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » ROA %

Guangdong Hybribio Biotech Co (SZSE:300639) ROA % : -14.07% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Guangdong Hybribio Biotech Co's annualized Net Income for the quarter that ended in Sep. 2024 was ¥-740.0 Mil. Guangdong Hybribio Biotech Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥5,258.3 Mil. Therefore, Guangdong Hybribio Biotech Co's annualized ROA % for the quarter that ended in Sep. 2024 was -14.07%.

The historical rank and industry rank for Guangdong Hybribio Biotech Co's ROA % or its related term are showing as below:

SZSE:300639' s ROA % Range Over the Past 10 Years
Min: -5.27   Med: 14.51   Max: 31.46
Current: -5.27

During the past 12 years, Guangdong Hybribio Biotech Co's highest ROA % was 31.46%. The lowest was -5.27%. And the median was 14.51%.

SZSE:300639's ROA % is ranked worse than
51.11% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: -4.52 vs SZSE:300639: -5.27

Guangdong Hybribio Biotech Co ROA % Historical Data

The historical data trend for Guangdong Hybribio Biotech Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Hybribio Biotech Co ROA % Chart

Guangdong Hybribio Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.85 17.40 24.00 31.46 2.25

Guangdong Hybribio Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.21 -2.14 -1.02 -4.57 -14.07

Competitive Comparison of Guangdong Hybribio Biotech Co's ROA %

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Hybribio Biotech Co's ROA % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's ROA % distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's ROA % falls into.


;
;

Guangdong Hybribio Biotech Co ROA % Calculation

Guangdong Hybribio Biotech Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=140.472/( (6741.177+5725.791)/ 2 )
=140.472/6233.484
=2.25 %

Guangdong Hybribio Biotech Co's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-739.976/( (5423.009+5093.63)/ 2 )
=-739.976/5258.3195
=-14.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Guangdong Hybribio Biotech Co  (SZSE:300639) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=-739.976/5258.3195
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-739.976 / 805.436)*(805.436 / 5258.3195)
=Net Margin %*Asset Turnover
=-91.87 %*0.1532
=-14.07 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Guangdong Hybribio Biotech Co ROA % Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Hybribio Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.
Executives
Xie Long Xu Directors, executives
Li Qing Hui Executives
Wang Jian Yu Directors, executives
Guan Zhi Sheng Directors, executives
Qiu Mei Lan Supervisors
Yuan Xian Securities Affairs Representative
Tang You Gen Independent director
Cai Dan Ping Director
Chen Yi Directors, executives
Xu Wan Jian Supervisors
Huang Wei Xiong Director
Guan Qiao Zhong Directors, executives

Guangdong Hybribio Biotech Co Headlines

No Headlines